Prognosis
White House Confident J&J Will Meet Vaccine Shipment Targets
- Production snag won’t quash order deadline, Psaki says
- Emergent says it’s confident it can get FDA authorization
This article is for subscribers only.
President Joe Biden’s administration is “assured” that Johnson & Johnson will meet its U.S. vaccine delivery targets despite a setback at a Baltimore site, White House Press Secretary Jen Psaki said.
Psaki spoke Thursday at the White House after J&J and one of its subcontractors, Emergent BioSolutions Inc., acknowledged that a batch of drug substance had been spoiled. She said the U.S. doesn’t expect J&J to miss any delivery targets, and alluded to having some room with a larger supply of Pfizer Inc. and Moderna Inc. The U.S. has said it will have enough vaccine doses for all American adults in May from those companies.